FDA-approved drug repurposing in zebrafish identifies thyroid hormone and other compounds as potential antithrombotics
Murat Yaman, Hongyu Su, Jacqueline K. Lee, Allison C. Ferguson, Katherine M Sowell, Jenny Xun, David Wu, Clayton J. Habiger, David A. Hanauer, Martin C. Clasby, Jason C. Rech, Jordan A. Shavit
This study uses zebrafish to screen FDA-approved drugs for antithrombotic effects, identifying thyroid hormone and others as potential treatments for VTE subtypes.
bioRxiv · Sep 23, 2025 · PreprintPharmacology & Toxicology